Cargando…
4-Nerolidylcatechol: apoptosis by mitochondrial mechanisms with reduction in cyclin D1 at G0/G1 stage of the chronic myelogenous K562 cell line
Context: 4-Nerolidylcatechol (4-NRC) has showed antitumor potential through apoptosis. However, its apoptotic mechanisms are still unclear, especially in leukemic cells. Objectives: To evaluate the cytotoxic potential of 4-NRC and its cell death pathways in p53-null K562 leukemic cells. Materials an...
Autores principales: | Benfica, Polyana Lopes, de Ávila, Renato Ivan, Rodrigues, Bruna dos Santos, Cortez, Alane Pereira, Batista, Aline Carvalho, Gaeti, Marilisa Pedroso Nogueira, Lima, Eliana Martins, Rezende, Kênnia Rocha, Valadares, Marize Campos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6130688/ https://www.ncbi.nlm.nih.gov/pubmed/28644062 http://dx.doi.org/10.1080/13880209.2017.1311351 |
Ejemplares similares
-
Stability and Antioxidant Activity of Semi-synthetic Derivatives of 4-Nerolidylcatechol
por: Lima, Emerson Silva, et al.
Publicado: (2012) -
Antioxidant effect of 4-nerolidylcatechol and
α-tocopherol in erythrocyte ghost membranes and phospholipid
bilayers
por: Fernandes, K.S., et al.
Publicado: (2013) -
Fangchinoline induces G0/G1 arrest by modulating the expression of CDKN1A and CCND2 in K562 human chronic myelogenous leukemia cells
por: WANG, YUPING, et al.
Publicado: (2013) -
Calcitonin receptor gene expression in K562 chronic myelogenous leukemic cells
por: Mould, Richard, et al.
Publicado: (2003) -
Inhibition of the Nrf2-TrxR Axis Sensitizes the Drug-Resistant Chronic Myelogenous Leukemia Cell Line K562/G01 to Imatinib Treatments
por: Xu, Lianrong, et al.
Publicado: (2019)